Senior Manager, Performance Analytics & Insights, Oncology - Breast Cancer

About the role

Global Commercial Analytics (GCA) harnesses the power of data to drive robust analytical insights that inform some of Pfizer’s most critical business decisions. Within Oncology, the Performance Analytics & Insights (PAI) team translates complex secondary data into commercial strategy, connecting what the data says to what the business does. The team sits at the intersection of brand strategy, patient access, and business performance, and its work directly shapes how Pfizer’s oncology portfolio reaches the patients who need it most. The Senior Manager of Performance Analytics & Insights will support the breast cancer franchise, tracking and interpreting commercial performance across the breast cancer portfolio — including brand demand, market share, biomarker‑defined patient segments, and subnational performance patterns — and translating those insights into clear, actionable narratives for brand teams and senior leadership.

Responsibilities

• Own end-to-end performance reporting for the breast cancer portfolio, including brand sales, TRx/NPS, market share, and attainment vs. targets across weekly, monthly, and quarterly cadences.
• Leverage secondary data sources (e.g., IQVIA, Symphony, specialty pharmacy, hub/SP data) to identify trends, surface risks and opportunities, and connect data signals to brand strategy decisions.
• Analyze performance through the lens of defined patient segments — including histology, biomarkers, patient demographics, lines of therapy, etc. — to understand how disease biology and treatment history shapes market dynamics, prescribing patterns, and patient flow across the treatment landscape.
• Apply subnational analytics to identify geographic variation in brand performance, patient segment penetration, and market dynamics — surfacing actionable insights for brand strategy without ownership of field operations or execution.
• Translate analytical findings into clear business narratives — leading with the “so what” and driving toward actionable recommendations for brand teams and leadership.
• Support the development and maintenance of the Oncology LT Dashboard and other enterprise reporting infrastructure, ensuring breast cancer metrics are accurate, timely, and decision‑ready.
• Proactively identify data anomalies, validate analytical outputs, and ensure every insight delivered to stakeholders is accurate and reliable.
• Serve as the secondary data analytics partner for the breast cancer team, providing data‑driven inputs that inform brand positioning, strategic planning, and commercial decision‑making.
• Partner with forecasting teams to provide accurate secondary data inputs — including demand trends, patient segment sizing, and market share dynamics — that inform volume and revenue projections.
• Identify emerging trends in the breast cancer treatment landscape — including evolving biomarker testing rates, treatment sequencing patterns, and competitive dynamics — and proactively frame the commercial implications for brand leadership.
• Partner with insights and strategy team members to connect patient journey data to brand strategy, identifying where patients are being lost along the diagnosis‑to‑treatment continuum and what that means for commercial priorities.
• Build trusted relationships with marketing, commercial excellence, data science, and